Youve developed some new health conditions: If you develop certain health conditions, such as thyroid cancer, your provider may recommend you stop taking semaglutide, since its not recommended for people with those conditions
Rotating injection sites with each dose prevents lipohypertrophy (fatty lumps under the skin) that can impair absorption
The primary aim of the present trial was to compare the effects of liraglutide 1.8 and 3.0 mg, the maximum approved dose in treatment of type 2 diabetes and the intended clinical dose in weight management, respectively, on gastric emptying in obese individuals without T2DM, with the focus on demonstrating equivalence between the two doses over a 5-h period, in order to support that no dose adjustment of concomitantly administered oral medications would be required during treatment with liraglutide 3.0 mg
Because of this, semaglutide is taken as a once-weekly injection, while liraglutide is taken as a once-daily injection
10.2337/db14-0558 33
See our complete research guide for background